46 results
8-K
EX-99.1
EQ
Equillium Inc
16 Oct 23
Regulation FD Disclosure
8:05am
inhibitors See full prescribing information for complete boxed warning. There remains a chronic need, * Increased risk of serious bacterial, fungal … , viral and for my AA patients” opportunistic infections leading to hospitalization or death, without a safe chronic treatment including tuberculosis (TB
425
bg8thbzx
28 Sep 22
Business combination disclosure
6:01am
425
hmztcj4v2opodehk2wv
27 Sep 22
Business combination disclosure
9:30am
8-K
EX-99.1
3ikmlof fmwj0w
27 Sep 22
Other Events
9:28am
8-K
EX-99.1
0xnfihc9
4 Mar 22
Equillium Announces Initiation of the Phase 3 EQUATOR Study of Itolizumab in First-line Acute Graft-Versus-Host Disease
2:00pm
8-K
EX-99.1
j4w i9p2ldh8z9g9h
2 Mar 22
Equillium Announces Appointment of Barbara Troupin to Board of Directors
9:00am
8-K
wogd9pcc wza
2 Mar 22
Equillium Announces Appointment of Barbara Troupin to Board of Directors
9:00am
8-K
EX-99.1
o6jgw
30 Mar 21
Equillium Announces Favorable Data From Phase 1b EQUALISE Study in Systemic Lupus Erythematosus Patients
4:52pm
8-K
EX-99.1
zre27r21853n2
9 Mar 21
Regulation FD Disclosure
7:00am
8-K
EX-99.1
1om0g5sq
7 Dec 20
Equillium Presents Translational Data Demonstrating Impact of Itolizumab on Effector T Cell
9:24am